Skip to main content

Advertisement

ADVERTISEMENT

Psoriasis News

News
12/21/2023
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to...
12/21/2023
First Report Managed Care
News
11/06/2023
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in...
11/06/2023
First Report Managed Care
News
10/13/2023
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that...
10/13/2023
First Report Managed Care

Advertisement

News
09/15/2023
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of...
09/15/2023
First Report Managed Care
News
08/29/2023
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well...
08/29/2023
First Report Managed Care
News
06/08/2023
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17...
06/08/2023
First Report Managed Care

Advertisement

News
05/16/2023
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to...
05/16/2023
First Report Managed Care
News
04/18/2023
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug...
04/18/2023
First Report Managed Care
News
03/07/2023
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic...
03/07/2023
First Report Managed Care

Advertisement

News
10/07/2022
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence...
10/07/2022
First Report Managed Care

Advertisement